Early steps in fusion between Epstein-Barr virus and a human hepatoma cell line (Li7A).
暂无分享,去创建一个
S. Grimaldi | S. Iacovacci | A. Lisi | G. Ravagnan | G. Carloni | D. Pozzi | G. Lanzilli | I. De Ros
[1] M. Clementi,et al. Co-amplification of transcriptionally active epidermal growth factor receptor and ribosomal genes in the human hepatoma cell line Li7A. , 1992, Oncogene.
[2] G. Nemerow,et al. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats , 1991, Journal of virology.
[3] S. Grimaldi,et al. Effect of erythrocyte transbilayer phospholipid distribution on fusion with vesicular stomatitis virus. , 1990, Biochemistry.
[4] N. Miller,et al. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus , 1988, Journal of virology.
[5] V. Baichwal,et al. Latency comes of age for herpesviruses , 1988, Cell.
[6] S. Grimaldi,et al. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. , 1986, Science.
[7] G. Klein,et al. Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells , 1982, Journal of virology.
[8] G. Lenoir,et al. Replication of Epstein-Barr virus: ultrastructural and immunofluorescent studies of P3HR1-superinfected Raji cells , 1977, Journal of virology.
[9] W. Henle,et al. Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.
[10] M. Epstein,et al. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.